The Changing Landscape of Global Vaccine Development and Market Potential - - BioPharm International

ADVERTISEMENT

The Changing Landscape of Global Vaccine Development and Market Potential


BioPharm International
Volume 20, Issue 10

30. Small EJ, Schellhammer PF, Higano CS, Redfern CH, Nemunaitis JJ, Valone FH, Verjee SS, Jones LA, Hershberg RM. Placebo-controlled Phase III trial of immunologic therapy with metastatic asymptomatic hormone refactory prostate cancer. J Clin Oncol. 2006, 24:3089-3094.

31. Todryk SM, Hill AVS. Malaria vaccines: the stage we are at. Nature Rev Microbiol. 2007;5:487-489.

32. Andersen P. Tuberculosis vaccines—an update. Nature Rev Microbiol. 2007;5:484-486.

33. De Groot AS, McMurry JA. TB vaccine development: opportunity and imperative. In: Moingeon P, editor. Vaccines: Frontiers in Design and Development. Norwich, UK: Horizon Bioscience; 2005. p. 167-182.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Suppliers Seek to Boost Single-Use Technology
August 21, 2014
Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen
August 20, 2014
USP Center in Ghana Receives International Lab Accreditation
August 15, 2014
USP Awards Analytical Research
August 15, 2014
FDA Warns about Fraudulent Ebola Treatments
August 15, 2014
Author Guidelines
Source: BioPharm International,
Click here